Mukhtar, Sameen, and Muhammad Haris. “Teplizumab: An FDA- Approved Drug, Marks Milestone in Treatment of Type 1 Diabetes”. International Journal of Scientific Reports 10, no. 1 (December 22, 2023): 29–30. Accessed April 29, 2025. https://www.sci-rep.com/index.php/scirep/article/view/1286.